Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Davunetide

EU orphan designation number: EU/3/10/728
Active ingredient: Davunetide
Indication: Treatment of progressive supranuclear palsy
Sponsor: FGK Representative Service GmbH
Heimeranstraße 35, D-80339 München, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/03/2010 Centralised Orphan - Designation EMEA/OD/129/09 (2010)2053 of 23/03/2010
19/04/2013 Centralised Orphan - Removal of orphan designation from Community Register